BRISTOL MYERS SQUIBB CO
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $48.2B | $48.3B | $45.0B | $46.2B | $46.4B |
| Cost of revenue | $13.9B | $14.0B | $10.7B | $10.1B | $9.9B |
| Selling, general & administrative | $7.3B | $8.4B | $7.8B | $7.8B | $7.7B |
| Research and development | $10.0B | $11.2B | $9.3B | $9.5B | $10.2B |
| Interest expense | $1.9B | $1.9B | $1.2B | $1.2B | $1.3B |
| Pretax income | $9.3B | -$8.4B | $8.4B | $7.7B | $8.1B |
| Income tax expense | $2.3B | $554.0M | $400.0M | $1.4B | $1.1B |
| Net income | $7.1B | -$8.9B | $8.0B | $6.3B | $7.0B |
| Balance Sheet | |||||
| Cash and equivalents | $10.2B | $10.3B | $11.5B | $9.1B | $14.0B |
| Current assets | $29.4B | $29.8B | $31.8B | $27.3B | $33.3B |
| Total assets | $90.0B | $92.6B | $95.2B | $96.8B | $109.3B |
| Current liabilities | $23.4B | $23.8B | $22.3B | $21.9B | $21.9B |
| Total liabilities | $71.5B | $76.2B | $65.7B | $65.7B | $73.3B |
| Total debt | — | — | $4.5B | $6.0B | — |
| Stockholders' equity | $18.5B | $16.3B | $29.4B | $31.1B | $35.9B |
| Cash Flow Statement | |||||
| Cash from operations | $14.2B | $15.2B | $13.9B | $13.1B | $16.2B |
| Depreciation and amortization | $4.0B | $9.6B | $9.8B | $10.3B | $10.7B |
| Stock-based compensation | $553.0M | $507.0M | $518.0M | $457.0M | $583.0M |
| Capital expenditure | $1.3B | $1.2B | $1.2B | $1.1B | $973.0M |
| Free cash flow | $12.8B | $13.9B | $12.7B | $11.9B | $15.2B |
| Dividends paid | $5.0B | $4.9B | $4.7B | $4.6B | $4.4B |
| Share repurchases | $0 | $0 | $5.2B | $8.0B | $6.3B |
| Impairments | — | — | — | — | $0 |
Shares outstanding 2.0B · Free float 99.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- May 8, 2026 8-K
- April 30, 2026 10-Q
- April 30, 2026 8-K
- February 11, 2026 10-K
- February 5, 2026 8-K
- January 12, 2026 8-K
- November 18, 2025 8-K
- November 10, 2025 8-K